HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Hill, R. A. Articles by Pell, J. M. Search for Related Content PubMed PubMed Citation Articles by Hill, R. A. Articles by Pell, J. M.

STAYING CURRENT

Antibodies as molecular mimics of biomolecules: roles in understanding physiological functions and mechanisms

¹ Department of Animal and Veterinary Science, University of Idaho, Moscow, Idaho ² Strathclyde Institute of Pharmacy and Biomedical Science, University of Strathclyde, Glasgow ³ The Babraham Institute, Cambridge, United Kingdom

Address for reprint requests and other correspondence: R. A. Hill, Dept. of Animal and Veterinary Science, Univ. of Idaho, PO Box 442330, Moscow, ID. 83844-2330 (e-mail: rodhill{at}uidaho.edu)

Abstract

Physiologists have routinely used understanding of the immune system to generate antibodies against regulatory molecules, growth factors, plasma membrane receptors, and other mammalian molecules in the development of analytical tools and assays. In taking this notion further, antibodies have been used in vivo to modulate physiological systems and to improve our understanding of their molecular interactions. To develop antibodies with physiological activity (efficacy), physiologists have worked with immunologists in developing interdisciplinary insights, requiring basic knowledge of immune system function in designing strategies to generate antibodies that interact with endogenous molecules of physiological interest, in vivo. Antibodies in different physiological systems have been shown to enhance or inhibit endogenous molecular functions. Two approaches have been used: passive and active immunization. Antibodies in these contexts have provided tools to develop further insights into molecular physiological mechanisms. Perhaps surprisingly, enhancing antibodies have been developed against a diverse set of target molecules including several members of the growth hormone/insulin-like growth factor-I axes and those of the β₂-adrenoceptor axis. Antibodies that inhibit the actions of somatostatin have also been developed. A further novel approach has been the development of antibodies that interact with adipose cells in vivo. These have the potential to be used in therapeutic antiobesity approaches. Antibodies with efficacy in vivo have provided new insights into molecular physiological mechanisms, enhancing our understanding of these complex processes.

Key words: growth hormone; insulin-like growth factor-1; somatostatin; β₂-adrenoceptor; adipocyte